TechTaffy

tech:

taffy

CoreSite Acquires Comfluent For $3M

By TechTaffy Desk

[Techtaffy Newsdesk]

CoreSite, a provider of  data centers, has purchased Comfluent, a carrier-neutral, network-centric colocation provider, located in Denver, Colorado. The purchase price is approximately $3 million along with the provision for earn-out payments over the next three years if certain operating and leasing hurdles are met.

Comfluent has around 75 customers, and manages the Rocky Mountain Internet eXchange (RMIX), the region’s largest Internet exchange with access to more than 25 networks. Comfluent currently leases two sites that total approximately 9,300 NRSF.

Alf Gardner, who founded Comfluent in 1997, will remain with CoreSite after the acquisition closes as general manager of Denver.

 

Just in

Industry

IBM, Canada, and Quebec invest $137M to strengthen semiconductor industry

IBM, the Government of Canada, and the Government of Quebec announced agreements to develop the assembly, testing and packaging capabilities for semiconductor modules at IBM Canada's plant in Bromont, Quebec.
Around the web

Net neutrality is back: U.S. promises fast, safe and reliable internet for all — NPR

Consumers can look forward to faster, safer and more reliable internet connections under the promises of newly reinstated government regulations, writes Emma Bowman of NPR.
AI

AI is ‘a new kind of digital species,’ Microsoft AI chief says — Quartz

Mustafa Suleyman, chief executive of Microsoft AI, said during a talk at TED 2024 that AI is the newest wave of creation since the start of life on Earth, and that “we are in the fastest and most consequential wave ever,” writes Britney Nguyen in Quartz.
Around the web

It’s baaack! Microsoft and IBM open source MS-DOS 4.0 — ZDNet

Microsoft and IBM have joined forces to open-source the 1988 operating system MS-DOS 4.0 under the MIT License, writes Steven Vaughan-Nichols. 
AI

Generative AI arrives in the gene editing world of CRISPR — NYT

New AI technology is generating blueprints for microscopic biological mechanisms that can edit your DNA, pointing to a future when scientists can battle illness and diseases with even greater precision and speed than they can today, writes Cade Metz.